The International Neuroblastoma Risk Groups (INRG): a preliminary report.
about
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastomaDownregulation of survivin by siRNA inhibits invasion and promotes apoptosis in neuroblastoma SH-SY5Y cells.Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells.PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma.Utility of transmission electron microscopy in small round cell tumors.Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT geneFanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case reportFluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children's Cancer Study Group.The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis.CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settingsThe value of anterior displacement of the abdominal aorta in diagnosing neuroblastoma in children.The connections between neural crest development and neuroblastoma.Cellular kinetics of neuroblastoma and the role of surgery.Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cellsDifferential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients.Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.Neuroblastoma management in Chinese children.High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.In vitro and in vivo downregulation of MRP1 by antisense oligonucleotides: a potential role in neuroblastoma therapy.Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma.
P2860
Q33893064-AD58E9BA-D5EE-4552-A18F-1D4238C60FCBQ34010661-5B6F2155-8A9B-47AC-87F7-5F9DF4FEB643Q34673584-597179EE-037A-432E-996E-565A31676AD0Q35078162-C24EBA4D-9A75-4617-AFA3-E9910F4833DCQ35198983-6A738533-FF16-452D-ADF5-AC3F11A6BE26Q36292779-864EF7E4-3B4A-4B52-AEFC-B3EA6D239007Q36503032-B9F5C953-1A9F-469C-8791-1DF828EB2ABFQ36641807-E9582780-96E5-451E-AA47-01C26A5FEEDAQ36692408-C75A855B-BC55-4BFE-BA53-EFBAC049B51FQ36790715-74D4E1AF-7D09-4819-8A31-1F58DBA16ACFQ37461968-A73B99D0-51AC-4B25-9A03-FC4F8D39C306Q37587649-65583839-EC2B-43F4-91AC-B7C3E0B773C5Q37836006-D00F60FB-DB92-4B64-BA08-3ADD7E45C006Q37902576-A29EFBA7-451B-45B8-BB90-45352DE17149Q38014527-5699272A-AD69-4F02-AD5A-6FFE1FD63C8CQ39883966-BD221490-449B-48C4-A48D-0146D3C13328Q41005589-0A7FAD81-B62D-49C6-8977-94823F63C8EAQ42413530-643694A7-7AD8-481F-8D20-C73440069B6AQ43169185-189B08E5-3878-40B7-A561-3DFD9A84FD62Q44632772-951B9A69-95D0-45CE-B80E-075A6EC2FD4FQ44960026-E2E9BCEE-6779-40BF-9103-AEBD8D525799Q45714420-43DB290D-81BE-415A-A45E-C84BD60803B8Q50563942-3A0CA31C-6D7C-42E7-903A-B9924F307402
P2860
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
@en
type
label
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
@en
prefLabel
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
@en
P2093
P1476
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
@en
P2093
B De Bernardi
C Dicks-Mireaux
F Berthold
G M Brodeur
J J Shuster
J M Michon
P304
P356
10.1016/S0959-8049(97)00202-5
P577
1997-10-01T00:00:00Z